lubiprostone has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, T; Node, K; Sato, E; Takeshita, M; Tanaka, A | 1 |
| Abe, T; Akiyama, Y; Fukuda, NN; Fukuda, S; Hirayama, A; Ito, S; Kikuchi, K; Mishima, E; Shima, H; Soga, T; Suzuki, C; Suzuki, T; Takeuchi, Y; Tomioka, Y; Yuri, A | 1 |
2 other study(ies) available for lubiprostone and Disease Exacerbation
| Article | Year |
|---|---|
Effect of Lubiprostone on Urinary Protein Excretion: A Report of Two IgA Nephropathy Patients with Chronic Constipation.
Topics: Adult; Chronic Disease; Constipation; Disease Progression; Fatty Acid-Binding Proteins; Female; Glomerulonephritis, IGA; Humans; Lubiprostone; Occult Blood; Proteinuria | 2019 |
Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.
Topics: Adenine; Alprostadil; Animals; Chloride Channel Agonists; Disease Progression; Drug Evaluation, Preclinical; Gastrointestinal Tract; Kidney Failure, Chronic; Lubiprostone; Male; Mice, Inbred C57BL; Microbiota; Random Allocation; Uremia | 2015 |